[{"Assets_0_Q2_USD":563300000.0,"CommonStockSharesOutstanding_0_Q2_shares":39831836.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":26549000.0,"NetIncomeLoss_1_Q2_USD":-59882000.0,"NetIncomeLoss_2_Q2_USD":-108625000.0,"StockholdersEquity_0_Q2_USD":356006000.0,"Ticker":"PRTA","CIK":"1559053","name":"PROTHENA CORP PLC","OfficialName":"Prothena Corporation plc Ordinary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1633142175.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]